Atlas Trials

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment

Clinical trial NCT06323837 · RECRUITING

Trial details

NCT number
NCT06323837
Sponsor
Washington State University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Stimulant Use Disorder
Start date
2024-06-17
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.